Garneau Severity Scale

Overview

The Garneau Severity Scale (GSS) is a standardized medical classification system used throughout Terran Diaspora and ISA-chartered medical facilities to assess the severity of anatomical anomalies, with particular sensitivity to cranial vascular malformations. Developed by Dr. Selene Garneau at the Hecht Station Medical Institute in 11,892 Standard Years, the scale provides a numeric framework from GSS-1 (incidental findings requiring no intervention) to GSS-10 (imminent catastrophic failure incompatible with continued neurological function).

The scale’s primary innovation was its integration of temporal-progression vectors alongside static anatomical measurements. Unlike predecessor classification systems that captured only a single diagnostic snapshot, the GSS quantifies rate of deterioration as a core severity multiplier. A malformation that measures GSS-4 on purely anatomical grounds may be elevated to GSS-7 if its progression velocity exceeds threshold values—a feature that makes the scale particularly relevant for triage decisions in settings where access to scanning equipment is intermittent or constrained.

Details

The Three-Axis Framework

The GSS operates on a ten-point integer scale, with half-point gradations permitted when clinical ambiguity prevents definitive integer assignment. Each level is defined by a weighted combination of three measurement axes:

• Anatomical Severity (Axis A): The size, location, and structural characteristics of the anomaly, measured in volumetric displacement from normative tissue architecture. Scored 0–10, with 10 representing complete architectural obliteration of the affected region.

• Functional Impact (Axis F): Quantified impairment of baseline function. For cranial vascular malformations, this includes pressure differentials across affected vessel segments, oxygenation efficiency in downstream neural tissue, and electrical conduction fidelity in adjacent neuronal clusters. Scored 0–10, with 10 representing complete functional collapse.

• Progression Velocity (Axis V): The temporal derivative of the combined A and F scores, measured in severity units per standard day. This axis distinguishes the GSS from all earlier classification systems. V-scores range from V-1 (stability or sub-clinical progression, no criticality projected within five standard years) to V-10 (acute deterioration with criticality projected within six standard hours).

The final GSS score is calculated as a weighted composite: (A × 0.3) + (F × 0.4) + (V × 0.3), rounded to the nearest integer. The Axis V weighting doubles when the malformation occupies a Class-1 neurological zone—specifically the brainstem, thalamic relay nuclei, or cortical language centres.

Severity Levels

The scale defines ten numeric levels, each carrying specific intervention timelines and clinical recommendations. At GSS-1, findings are incidental with no intervention required. GSS-3 through GSS-5 represent progressively urgent but elective surgical windows. GSS-6 marks the threshold where FTL transit is restricted due to decompensation risk. GSS-7 triggers a 72-hour intervention window and represents a critical bureaucratic threshold: at this level, the ISA’s Emergency Maintenance Access Provisions can override standard warranty enforcement on medical equipment. GSS-8 compresses the intervention window to 12 hours. GSS-9 indicates active functional system failure with life support likely required. GSS-10 classifies intervention as probably futile, with palliative care as the recommended course.

Progression Velocity Calculation

Temporal-progression vectors are calculated from a minimum of two imaging sessions separated by at least 24 standard hours. The V-axis uses a logarithmic reference table calibrated to the malformation’s anatomical class. In emergency settings where prior imaging is unavailable, a provisional V-score can be assigned based on radiographic indicators of acute deterioration—tissue oedema patterns, haemorrhagic micro-foci, or contrast extravasation—and flagged as “V-Prov” until confirmation or revision within 72 hours.

Anatomical Modifiers

The scale applies several modifiers based on malformation location. Class-1 zones (brainstem, thalamic relay nuclei, Broca’s area, Wernicke’s area, primary motor cortex) receive a 1.5× multiplier on V-score weighting because surrounding neural architecture cannot compensate for progressive impairment. Class-2 zones (cerebellum, basal ganglia, primary sensory cortices) receive a 1.2× multiplier. Class-3 zones (frontal association cortex, occipital lobe, non-dominant hemisphere regions) receive no multiplier due to their significant plasticity. Additional flags exist for peduncular involvement (+1 to final GSS) and multi-focal presentation (+0.5 per additional discrete malformation).

Gravitic Imaging Requirements

Formal GSS assignment requires imaging data collected under the Garneau Imaging Protocol (GIP-4.2), which specifies minimum gravitic field resolution, tissue density mapping with ISA-certified contrast agents, and equipment that has passed calibration verification within the preceding 30 standard days using an ISA-certified calibration tool. This last requirement has significant implications: imaging data from equipment with lapsed or voided calibration certification cannot legally support GSS score assignment, even if the equipment remains physically capable of producing diagnostically adequate images.

Bureaucratic Integration

The GSS interfaces with ISA warranty enforcement through the Emergency Maintenance Access Provisions (EMAP). When a physician assigns a GSS score of 7 or higher, the score transmits to the local Clause-Tether network as a priority interrupt. The attending physician must then provide real-time biometric confirmation—retinal scan plus voiceprint—that the score assignment is clinically valid. Upon validation, the Tether temporarily suspends warranty-based equipment lockouts for a duration calibrated to the GSS level: 72 hours at GSS-7, 24 hours at GSS-8, and 6 hours at GSS-9. At GSS-10, the override pathway is closed entirely. The physician must concurrently file Form 27B-Stroke-6 with the GSS EMAP Addendum documenting the clinical necessity. Failure to file within the override window results in retroactive nullification and automatic reporting to the ISA Medical Compliance Board.

Significance

The Garneau Severity Scale occupies a unique position among medical classification systems as one of the few granted direct physical enforcement authority under the ISA’s Warranty Enforcement Division. It functions not merely as a clinical tool but as a bureaucratic key capable of unlocking equipment held hostage by warranty enforcement—a safeguard designed to ensure that contractual fine print cannot directly cause patient deaths.

In practice, this integration has produced a troubling paradox. The scale’s activation requires diagnostic imaging from equipment that meets strict calibration standards, yet those same standards are enforced by the very warranty system the scale is meant to override. Equipment flagged for calibration violations becomes incapable of generating legally valid GSS scores, closing off the EMAP override pathway entirely and leaving patients trapped between escalating medical need and immovable bureaucratic enforcement. The time required for biometric validation and form filing has been documented to consume between 11 and 47 percent of the override window in high-traffic facilities, transforming physician speed at paperwork into a de facto clinical skill.

The current edition, GSS-4.2, has remained in effect for 187 standard years. Revision 4.3 has been stalled in the ISA Committee of Proper Response for 34 years due to a procedural dispute over the definition of “impending” in the GSS-9 criteria. This immutability reflects a broader reality of the ISA’s procedural architecture: medical classification systems become effectively frozen at their current revision, because any change would require re-validation of every Clause-Tether enforcement parameter that references the scale. The GSS thus embodies the tension between clinical adaptability and bureaucratic consistency, a tool designed with compassionate intent that has become, in the hands of an absolutist enforcement apparatus, a mechanism capable of elegantly rationalized harm.